While the predictive value of programmed cell death ligand-1 (PD-L1) protein expression for immune checkpoint inhibitor therapy of lung cancer has been extensively studied, the impact of standard platinum-based chemotherapy on PD-L1 or programmed cell death-1 (PD-1) expression is unknown. The ...
treatmentoflungcancer(肺癌的治疗方法)课件.ppt,Treatment of Lung Cancer01Feb2015 ContentIntroductionChemotherapyRadiotherapyImmunotherapyTargetted therapySymptoms and SignsSurgery 2024/5/24Introduction肺癌目前是全世界癌症死因的第一名。1995年全世界有60万人
Main Page | Risk Factors | Symptoms | Diagnosis | Treatment | Screening | Reducing Your Risk | Talking to Your Doctor | Living With Lung Cancer | Resource Guide How Chemotherapy Works Chemotherapy uses drugs to kill cancer cells. The drugs enter the bloodstream and travel through the body in...
参考文献: [1]Forde PM,Spicer J,Lu S,et al.CheckMate 816 Investigators.Neoadjuvant Nivolumab plus Chemotherapy in Resectable Lung Cancer.N Engl J Med.2022 May 26;386(21):1973-1985. [2]Zhong WZ,Chen KN,Chen C,et al.Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment ofStage...
Lung cancer is the primary cause of mortality in the United States and around the globe. Therapeutic options for lung cancer treatment include surgery, radiation therapy, chemotherapy, and targeted drug therapy. Medical management is often associated wit
Combination cyclophosphamide, adriamycin, and vincristine rapidly alternating with combination cisplatin and VP-16 in treatment of small cell lung cancer Forty-four patients with small cell lung cancer were treated with an intensive chemotherapy induction program consisting of combination cyclophosphamide, A....
[5] Santos ES.Treatment options after first-line immunotherapy in metastatic NSCLC.Expert Rev Anticancer Ther.2020 Mar;20(3):221-228. [6] Datopotamab deruxtecan (Dato-DXd) in patients with previously treated advanced ...
Benjamin P. Levy, MD:For most of my patients—and we didn’t talk about this in the first-line—we are offering these patients who tolerate treatment and who are at least achieving stable disease after four cycles, maintenance chemotherapy. And that affords us the ability to follow these pa...
AimsPalliative chemotherapy in non-small cell lung cancer (NSCLC) has been established since 1995 and little chemotherapy treatment was given to these patients before 1990. This retrospective study investigates the treatment outcome of elderly patients (age≥70 years) with NSCLC over the past 13 year...
肺癌治疗方法TreatmentofLungCancer.ppt,Treatment-化疗 化疗的不良反应 药物对血管内膜的刺激可引起静脉炎 骨髓抑制: 最主要且最常见的不良反应,发生在化疗后8~14天, 主要表现为白细胞,红细胞,血小板降低 胃肠道反应: 恶心,呕吐,腹泻,便秘,食欲减退 其他 肾功能